Navigation Links
Energy Supplement Under Study for Parkinson's Disease

Whether a supplement used by athletes to boost energy levels and build muscle can slow progression of Parkinson’s disease is the focus of a North American study. //

Creatine, under study for a number of neurological and neuromuscular diseases such as Lou Gehrig’s and muscular dystrophy, may help Parkinson’s patients by giving an energy boost to dying cells, says Dr. Kapil D. Sethi, neurologist and director of the Movement Disorders Program at the Medical College of Georgia.

“We think it may help cells that are damaged or overworked,” says Dr. Sethi, a site principal investigator on the National Institute of Neurological Disorders and Stroke study. MCG hopes to recruit 45 patients for the study that will enroll 1,720 patients at 51 sites in the United States and Canada.

Mitochondria, the powerhouse for cells, become dysfunctional in the brain, muscle and platelet cells of many patients with Parkinson’s disease, Dr. Sethi says. Powerhouse dysfunction is discernible in postmortem brain studies and in muscle biopsies and measures of platelet activity in the living.

“By giving more energy to the cell, you are giving them a safety margin,” Dr. Sethi says. “If a cell is dying, it takes another route and that would be surviving.”

The goal is to slow progression of a disease that affects about 1 million people in North America. Hallmarks include tremors, rigidity and slowed movement. Late in the disease, the majority of patients also develop dementia and behavior disorders.

Today’s therapies – including the gold standard, a synthetic dopamine called levodopa and MAO-B inhibitors that forestall breakdown of dopamine – are geared toward treating symptoms. Dopamine, a neurotransmitter critical to movement, is depleted in Parkinson’s. Researchers hope newer therapies, including creatine, can be added to the mix to help slow the disease.

The creatine study will enroll patients who have been on stan dard therapies from 90 days to two years and follow them for five years. Half the enrollees will get creatine and half placebo. The hope is for at least a 20 percent reduction in disease progression, so that at the end of five years, patients on creatine will look like placebo patients at four years, says Buff Dill, MCG study coordinator.

A number of methods will be used to periodically measure disease progression, including the Unified Parkinson’s Disease Rating Scale.

Following disease progression over many years and measuring endpoints such as falling, nursing home placement, dementia and death is the only way to effectively assess treatment for a disease that typically progresses slowly, Dr. Sethi says. In fact, the study may be extended five more years, based on preliminary results and funding, he says.

Those who get creatine may have the added benefit of increased muscle, as is true of athletes, Dr. Sethi says, noting that many patients experience muscle atrophy and weight loss.

Although creatine is available over the counter, he believes Parkinson’s patients will still be interested in the study. “Patients realize that we don’t know if it works. They are willing to take the risk of being on placebo for the cause of science and to learn more about the disease,” he says, noting the altruistic nature of many of his patients. “They want to beat this disease and if they can’t, they want to help somebody else beat it.”

Avicena Group, Inc., will provide creatine and placebo for this first large study in a series of National Institutes of Health-sponsored exploratory trials in Parkinson’s.

MCG will participate in a similar study of coenzyme Q10, another natural supplement that boosts energy production, later this year. Dr. Sethi, project director of the Parkinson Research Alliance of India, which is working to bring more clinical trials to his homeland, plans to incorporate these supplements into innovative treatment cocktails that will be studied there.


Sorce-Eurekalert
SRM
'"/>




Related medicine news :

1. Radiofrequency Energy Cooks Tumors Without Surgery
2. Energy intake directly related to portion size
3. Energy Therapy For Quicker Healing
4. Pollution Free Hydrogen based fuel for Energy
5. Obesity Can Be Caused By Consumption Of Energy Drinks
6. Bird Flu Likely To Reduce World Energy Demand
7. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
8. Energy Security Boosted by ADB in Asia
9. Boosting Energy Naturally
10. "Dynamic Energy Landscape" of enzyme in Catalysis
11. High-Energy Clamp Simplifies Heart Surgery for Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
Breaking Medicine Technology: